ICOSAPENT ETHYL

ICOSAPENT ETHYL was reported 8757 times

These side effects are most commonly reported by patients taking ICOSAPENT ETHYL:

# Side effect Count
0 PRODUCT ODOUR ABNORMAL 1055
1 PRODUCT PHYSICAL ISSUE 916
2 OFF LABEL USE 796
3 POOR QUALITY PRODUCT ADMINISTERED 669
4 DIARRHOEA 614
5 DRUG INEFFECTIVE 585
6 NAUSEA 552
7 ARTHRALGIA 501
8 FATIGUE 462
9 PRODUCT TASTE ABNORMAL 451
10 PRESCRIBED UNDERDOSE 314
11 BLOOD TRIGLYCERIDES INCREASED 312
12 HEADACHE 311
13 DIZZINESS 305
14 CONDITION AGGRAVATED 286
15 ERUCTATION 281
16 ABDOMINAL DISCOMFORT 278
17 VOMITING 273
18 PAIN 269
19 PAIN IN EXTREMITY 267
20 DYSPNOEA 255
21 RASH 246
22 DEATH 242
23 PRODUCT DOSE OMISSION ISSUE 240
24 WEIGHT INCREASED 227
25 THERAPY INTERRUPTED 226
26 PRODUCT COLOUR ISSUE 225
27 ASTHENIA 215
28 BLOOD GLUCOSE INCREASED 215
29 PRURITUS 213
30 NASOPHARYNGITIS 207
31 ABDOMINAL PAIN UPPER 205
32 PERIPHERAL SWELLING 202
33 INSOMNIA 197
34 HYPOAESTHESIA 189
35 HYPERTENSION 186
36 MYALGIA 180
37 CONSTIPATION 179
38 MOBILITY DECREASED 179
39 URTICARIA 179
40 MALAISE 174
41 DECREASED APPETITE 168
42 SINUSITIS 164
43 BLOOD PRESSURE INCREASED 162
44 WEIGHT DECREASED 162
45 PYREXIA 161
46 MATERNAL EXPOSURE DURING PREGNANCY 160
47 MUSCLE SPASMS 159
48 INTENTIONAL UNDERDOSE 158
49 ALOPECIA 155
50 DYSPEPSIA 154
51 PNEUMONIA 154
52 PSORIATIC ARTHROPATHY 154
53 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 147
54 JOINT SWELLING 146
55 PRODUCT ADHESION ISSUE 146
56 TYPE 2 DIABETES MELLITUS 145
57 BACK PAIN 144
58 RHEUMATOID ARTHRITIS 142
59 SWELLING 142
60 UNDERDOSE 141
61 ATRIAL FIBRILLATION 137
62 MUSCULOSKELETAL PAIN 135
63 DRUG HYPERSENSITIVITY 133
64 FALL 132
65 STOMATITIS 130
66 COVID-19 127
67 DRUG INTOLERANCE 126
68 DYSGEUSIA 126
69 PRODUCT USE ISSUE 124
70 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 123
71 ARTHROPATHY 122
72 COUGH 118
73 BLOOD CHOLESTEROL INCREASED 117
74 CHEST PAIN 115
75 MYOCARDIAL INFARCTION 114
76 OSTEOARTHRITIS 114
77 ANXIETY 113
78 DRUG-INDUCED LIVER INJURY 112
79 FIBROMYALGIA 112
80 ABDOMINAL PAIN 110
81 PRODUCT USE IN UNAPPROVED INDICATION 110
82 HEPATIC ENZYME INCREASED 109
83 FEELING ABNORMAL 108
84 GASTROOESOPHAGEAL REFLUX DISEASE 108
85 CONFUSIONAL STATE 106
86 DRUG INTERACTION 105
87 ACUTE KIDNEY INJURY 104
88 SCIATICA 104
89 CHRONIC KIDNEY DISEASE 101
90 CONTUSION 101
91 GAIT DISTURBANCE 101
92 C-REACTIVE PROTEIN INCREASED 100
93 PRODUCT LEAKAGE 100
94 PRODUCT STORAGE ERROR 99
95 BRONCHITIS 98
96 HELICOBACTER INFECTION 98
97 PRODUCT SIZE ISSUE 97
98 HYPERSENSITIVITY 96
99 TREATMENT FAILURE 93
100 CEREBROVASCULAR ACCIDENT 92
101 CONTRAINDICATED PRODUCT ADMINISTERED 92
102 ROAD TRAFFIC ACCIDENT 91
103 THERAPEUTIC PRODUCT EFFECT DECREASED 91
104 MEMORY IMPAIRMENT 90
105 URINARY TRACT INFECTION 90
106 LOWER RESPIRATORY TRACT INFECTION 89
107 RETCHING 89
108 INTENTIONAL PRODUCT USE ISSUE 88
109 PEMPHIGUS 87
110 MUSCLE INJURY 86
111 WHEEZING 86
112 SYNOVITIS 85
113 HOSPITALISATION 84
114 PERICARDITIS 84
115 INFECTION 83
116 PLATELET COUNT DECREASED 83
117 SYSTEMIC LUPUS ERYTHEMATOSUS 83
118 GENERAL PHYSICAL HEALTH DETERIORATION 82
119 INJECTION SITE PAIN 81
120 OEDEMA 81
121 THERAPEUTIC RESPONSE UNEXPECTED 81
122 ARTHRITIS 80
123 LIVER INJURY 80
124 WHITE BLOOD CELL COUNT DECREASED 80
125 HAND DEFORMITY 79
126 ABDOMINAL DISTENSION 78
127 INFUSION RELATED REACTION 78
128 MUSCULOSKELETAL STIFFNESS 78
129 PALPITATIONS 77
130 DYSPHAGIA 76
131 OEDEMA PERIPHERAL 76
132 RENAL IMPAIRMENT 76
133 ADVERSE EVENT 75
134 GOUT 75
135 INCORRECT DOSE ADMINISTERED 75
136 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 75
137 MIGRAINE 75
138 OVERLAP SYNDROME 75
139 DEPRESSION 74
140 DIABETES MELLITUS 73
141 RENAL FAILURE 73
142 ALANINE AMINOTRANSFERASE INCREASED 72
143 DRY MOUTH 72
144 FLATULENCE 72
145 LIP DRY 72
146 SOMNOLENCE 72
147 ASTHMA 71
148 CATARACT 71
149 GASTROINTESTINAL DISORDER 71
150 INFLAMMATION 71
151 WOUND INFECTION 70
152 ADVERSE DRUG REACTION 69
153 ANAEMIA 69
154 DUODENAL ULCER PERFORATION 69
155 SLEEP DISORDER 69
156 HYPOTENSION 68
157 MUSCULAR WEAKNESS 68
158 OBESITY 68
159 PANCREATITIS 68
160 PARAESTHESIA 67
161 PRESCRIBED OVERDOSE 67
162 HEPATIC CIRRHOSIS 66
163 OROPHARYNGEAL PAIN 66
164 DIVERTICULITIS 64
165 FACET JOINT SYNDROME 64
166 HEART RATE INCREASED 64
167 VISUAL IMPAIRMENT 63
168 DISCOMFORT 62
169 BURSITIS 61
170 ILLNESS 61
171 LOWER LIMB FRACTURE 60
172 ANAPHYLACTIC REACTION 59
173 BREAST CANCER STAGE III 59
174 C-REACTIVE PROTEIN ABNORMAL 59
175 LIVE BIRTH 59
176 EPILEPSY 58
177 THERAPY NON-RESPONDER 58
178 NAIL DISORDER 55
179 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 55
180 TREMOR 55
181 HERPES ZOSTER 54
182 INJURY 54
183 RED BLOOD CELL SEDIMENTATION RATE INCREASED 54
184 IMPAIRED HEALING 53
185 PRODUCT QUALITY ISSUE 53
186 DEHYDRATION 52
187 OSTEOPOROSIS 52
188 HERNIA 51
189 HOT FLUSH 51
190 LUNG DISORDER 51
191 PRODUCT USE COMPLAINT 51
192 EYE DISORDER 50
193 CYSTITIS 49
194 ERYTHEMA 49
195 NEPHROLITHIASIS 49
196 PRODUCT COATING ISSUE 49
197 PRODUCT RESIDUE PRESENT 49
198 PULMONARY FIBROSIS 49
199 BLISTER 48
200 LIVER DISORDER 48
201 BLOOD PRESSURE DECREASED 47
202 GAIT INABILITY 47
203 HEPATOTOXICITY 47
204 INFLUENZA 47
205 C-REACTIVE PROTEIN 46
206 CHEST DISCOMFORT 46
207 INTENTIONAL PRODUCT MISUSE 46
208 IRRITABLE BOWEL SYNDROME 46
209 NECK PAIN 46
210 RASH PRURITIC 46
211 SEPSIS 46
212 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 45
213 GLAUCOMA 45
214 HEPATIC ENCEPHALOPATHY 45
215 MULTIPLE ALLERGIES 45
216 MYELOSUPPRESSION 45
217 CATARACT OPERATION 44
218 COLITIS MICROSCOPIC 44
219 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44
220 HYPERHIDROSIS 44
221 SKIN REACTION 44
222 THERAPY CESSATION 44
223 WOUND 44
224 IMMUNODEFICIENCY 43
225 LOSS OF CONSCIOUSNESS 43
226 PSORIASIS 43
227 EPISTAXIS 42
228 FOLLICULITIS 42
229 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 42
230 NEUROPATHY PERIPHERAL 42
231 PRODUCT DOSE OMISSION 42
232 RHEUMATIC DISORDER 42
233 VISION BLURRED 42
234 BALANCE DISORDER 41
235 BLOOD CREATININE INCREASED 41
236 GLOSSODYNIA 41
237 JOINT RANGE OF MOTION DECREASED 41
238 MULTIPLE FRACTURES 41
239 NIGHT SWEATS 41
240 PRODUCT DISPENSING ERROR 41
241 BLOOD ALKALINE PHOSPHATASE INCREASED 40
242 DRUG RESISTANCE 39
243 EYE PAIN 39
244 HEPATIC NECROSIS 39
245 RHEUMATIC FEVER 39
246 BLOOD GLUCOSE DECREASED 38
247 CARDIAC FAILURE 38
248 EMOTIONAL DISTRESS 38
249 FREQUENT BOWEL MOVEMENTS 38
250 UPPER RESPIRATORY TRACT INFECTION 38
251 CHILLS 37
252 EAR INFECTION 37
253 END STAGE RENAL DISEASE 37
254 INTENTIONAL DOSE OMISSION 37
255 RHINORRHOEA 37
256 TASTE DISORDER 37
257 ASPARTATE AMINOTRANSFERASE INCREASED 36
258 THERAPEUTIC RESPONSE DECREASED 36
259 TREATMENT NONCOMPLIANCE 36
260 CARDIAC DISORDER 35
261 EXPOSURE DURING PREGNANCY 35
262 HEPATIC ENZYME ABNORMAL 35
263 LIVER FUNCTION TEST INCREASED 35
264 CARDIAC FAILURE CONGESTIVE 34
265 HYPOKALAEMIA 34
266 IMPAIRED GASTRIC EMPTYING 34
267 NO ADVERSE EVENT 34
268 FLUSHING 33
269 GLYCOSYLATED HAEMOGLOBIN INCREASED 33
270 HAEMOGLOBIN DECREASED 33
271 HYPERCHOLESTEROLAEMIA 33
272 INJECTION SITE BRUISING 33
273 PRODUCT AFTER TASTE 33
274 BLOOD IMMUNOGLOBULIN A DECREASED 32
275 BLOOD IMMUNOGLOBULIN G INCREASED 32
276 BLOOD IMMUNOGLOBULIN M INCREASED 32
277 CORONARY ARTERY DISEASE 32
278 DYSPHONIA 32
279 ILL-DEFINED DISORDER 32
280 STRESS 32
281 DRY SKIN 31
282 KNEE ARTHROPLASTY 31
283 RHEUMATOID FACTOR POSITIVE 31
284 SYNCOPE 31
285 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31
286 ANHEDONIA 30
287 DRUG DOSE OMISSION 30
288 EYE IRRITATION 30
289 HAEMORRHAGE 30
290 INJECTION SITE ERYTHEMA 30
291 PLEURAL EFFUSION 30
292 PULMONARY EMBOLISM 30
293 RETINITIS 30
294 SURGERY 30
295 THROMBOSIS 30
296 ULCER HAEMORRHAGE 30
297 AUTOIMMUNE DISORDER 29
298 BLOOD TRIGLYCERIDES ABNORMAL 29
299 DRUG TOLERANCE DECREASED 29
300 HIP ARTHROPLASTY 29
301 INTERSTITIAL LUNG DISEASE 29
302 NASAL CONGESTION 29
303 PERIPHERAL VENOUS DISEASE 29
304 POLLAKIURIA 29
305 SKIN EXFOLIATION 29
306 SWOLLEN JOINT COUNT INCREASED 29
307 DEVICE ISSUE 28
308 FEELING HOT 28
309 PRODUCT CONTAINER ISSUE 28
310 CROHN^S DISEASE 27
311 GASTROINTESTINAL HAEMORRHAGE 27
312 LOW DENSITY LIPOPROTEIN INCREASED 27
313 RECTAL HAEMORRHAGE 27
314 CHOKING 26
315 DEEP VEIN THROMBOSIS POSTOPERATIVE 26
316 HEPATIC FUNCTION ABNORMAL 26
317 HYPERTRIGLYCERIDAEMIA 26
318 JOINT DISLOCATION 26
319 HEPATIC STEATOSIS 25
320 HYPOTHYROIDISM 25
321 PRODUCT DOSE OMISSION IN ERROR 25
322 SWELLING FACE 25
323 AMNESIA 24
324 DELIRIUM 24
325 FLUID RETENTION 24
326 LUPUS VULGARIS 24
327 INFLUENZA LIKE ILLNESS 23
328 INJECTION SITE PRURITUS 23
329 MILK-ALKALI SYNDROME 23
330 OCULAR HYPERAEMIA 23
331 PORPHYRIA ACUTE 23
332 TACHYCARDIA 23
333 ACCIDENTAL EXPOSURE TO PRODUCT 22
334 BURNING SENSATION 22
335 DRY EYE 22
336 HAEMATOCHEZIA 22
337 HYPOPHOSPHATAEMIA 22
338 MALIGNANT NEOPLASM PROGRESSION 22
339 RENAL DISORDER 22
340 WEIGHT FLUCTUATION 22
341 BLEPHAROSPASM 21
342 BLOOD POTASSIUM DECREASED 21
343 DISLOCATION OF VERTEBRA 21
344 EXOSTOSIS 21
345 GLOMERULAR FILTRATION RATE DECREASED 21
346 HALLUCINATION 21
347 HYPERKALAEMIA 21
348 INCREASED APPETITE 21
349 JOINT STIFFNESS 21
350 LETHARGY 21
351 PRODUCT AVAILABILITY ISSUE 21
352 THROAT IRRITATION 21
353 CELLULITIS 20
354 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20
355 CORONARY ARTERY OCCLUSION 20
356 DEEP VEIN THROMBOSIS 20
357 DISTURBANCE IN ATTENTION 20
358 FOOT DEFORMITY 20
359 INSURANCE ISSUE 20
360 LUPUS-LIKE SYNDROME 20
361 NEUTROPENIA 20
362 SEPTIC SHOCK 20
363 X-RAY ABNORMAL 20
364 BACK DISORDER 19
365 BONE EROSION 19
366 BONE PAIN 19
367 DEVICE DIFFICULT TO USE 19
368 FEEDING DISORDER 19
369 INJECTION SITE SWELLING 19
370 MEDICATION ERROR 19
371 PAIN IN JAW 19
372 ACUTE MYOCARDIAL INFARCTION 18
373 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 18
374 BLOOD PRESSURE ABNORMAL 18
375 COLITIS ULCERATIVE 18
376 DEVICE MALFUNCTION 18
377 EXPIRED PRODUCT ADMINISTERED 18
378 HYPOGLYCAEMIA 18
379 NEPHROGENIC ANAEMIA 18
380 OXYGEN SATURATION DECREASED 18
381 PREGNANCY 18
382 RESPIRATORY DISORDER 18
383 SEIZURE 18
384 STENT PLACEMENT 18
385 UNEVALUABLE EVENT 18
386 ACUTE RESPIRATORY FAILURE 17
387 BACK INJURY 17
388 BLOOD CREATINE PHOSPHOKINASE INCREASED 17
389 BLOOD POTASSIUM INCREASED 17
390 CARDIAC FLUTTER 17
391 ECZEMA 17
392 HAEMATURIA 17
393 HIGH DENSITY LIPOPROTEIN DECREASED 17
394 HYPOMAGNESAEMIA 17
395 IMMUNE SYSTEM DISORDER 17
396 IRRITABILITY 17
397 LABORATORY TEST ABNORMAL 17
398 RENAL INJURY 17
399 SERONEGATIVE ARTHRITIS 17
400 SINUS DISORDER 17
401 TINNITUS 17
402 TRANSIENT ISCHAEMIC ATTACK 17
403 ACCIDENTAL OVERDOSE 16
404 ARRHYTHMIA 16
405 BREAST CANCER 16
406 CEREBRAL INFARCTION 16
407 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16
408 DEPRESSED MOOD 16
409 DYSSTASIA 16
410 EYE SWELLING 16
411 FOREIGN BODY IN THROAT 16
412 GASTRIC ULCER 16
413 HYPERLIPIDAEMIA 16
414 INJECTION SITE HAEMORRHAGE 16
415 INJECTION SITE MASS 16
416 LACRIMATION INCREASED 16
417 LARYNGITIS 16
418 LIMB DISCOMFORT 16
419 LIP SWELLING 16
420 MUSCLE TIGHTNESS 16
421 NERVOUSNESS 16
422 PANCREATITIS ACUTE 16
423 PRODUCT ADMINISTRATION INTERRUPTED 16
424 PRODUCT LABEL ISSUE 16
425 RASH ERYTHEMATOUS 16
426 THIRST 16
427 WHITE BLOOD CELL COUNT INCREASED 16
428 ANGINA PECTORIS 15
429 BONE DENSITY DECREASED 15
430 DISEASE RECURRENCE 15
431 EAR PAIN 15
432 FOOT FRACTURE 15
433 GRIP STRENGTH DECREASED 15
434 HEART RATE IRREGULAR 15
435 INJECTION SITE REACTION 15
436 LIMB INJURY 15
437 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15
438 NEOPLASM MALIGNANT 15
439 NEURALGIA 15
440 PRODUCT DISPENSING ISSUE 15
441 PRODUCT SUBSTITUTION ISSUE 15
442 PRODUCTIVE COUGH 15
443 SEASONAL ALLERGY 15
444 SKIN DISCOLOURATION 15
445 SKIN ODOUR ABNORMAL 15
446 SPONDYLITIS 15
447 URINE ODOUR ABNORMAL 15
448 VIRAL INFECTION 15
449 ADRENAL INSUFFICIENCY 14
450 ASPIRATION 14
451 BLOOD TEST ABNORMAL 14
452 CARDIAC OPERATION 14
453 DIABETIC KETOACIDOSIS 14
454 FAECES DISCOLOURED 14
455 FOETAL EXPOSURE DURING PREGNANCY 14
456 HYPERTRANSAMINASAEMIA 14
457 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14
458 INTESTINAL OBSTRUCTION 14
459 JOINT INJURY 14
460 METABOLIC ACIDOSIS 14
461 MYASTHENIA GRAVIS 14
462 OSTEOPENIA 14
463 PNEUMONIA ASPIRATION 14
464 PRODUCT ADMINISTRATION ERROR 14
465 PRODUCT PRESCRIBING ERROR 14
466 URINARY RETENTION 14
467 VERTIGO 14
468 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 13
469 BRAIN FOG 13
470 BREATH ODOUR 13
471 CARDIAC ARREST 13
472 CHROMATURIA 13
473 DISABILITY 13
474 EYE PRURITUS 13
475 LOCALISED INFECTION 13
476 OVERDOSE 13
477 PERICARDIAL EFFUSION 13
478 POOR QUALITY SLEEP 13
479 REGURGITATION 13
480 RHABDOMYOLYSIS 13
481 SARS-COV-2 TEST POSITIVE 13
482 TROPONIN INCREASED 13
483 ULCER 13
484 WALKING AID USER 13
485 ACCIDENTAL UNDERDOSE 12
486 AGEUSIA 12
487 BACTERIAL INFECTION 12
488 BENIGN PROSTATIC HYPERPLASIA 12
489 BLOOD GLUCOSE FLUCTUATION 12
490 BLOOD URIC ACID INCREASED 12
491 BRADYCARDIA 12
492 CARDIOVASCULAR DISORDER 12
493 COLITIS 12
494 CORONARY ARTERY BYPASS 12
495 DIZZINESS POSTURAL 12
496 FOOD ALLERGY 12
497 FULL BLOOD COUNT ABNORMAL 12
498 FUNGAL INFECTION 12
499 GLUCOSE TOLERANCE IMPAIRED 12
500 HYPERPARATHYROIDISM SECONDARY 12
501 HYPOACUSIS 12
502 HYPOPHAGIA 12
503 INFUSION SITE REACTION 12
504 MASS 12
505 MEDICATION RESIDUE PRESENT 12
506 MUSCULOSKELETAL DISCOMFORT 12
507 ONYCHOMADESIS 12
508 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12
509 PRESYNCOPE 12
510 PRODUCT CONTAINER SEAL ISSUE 12
511 PROSTATE CANCER 12
512 PULMONARY ARTERIAL HYPERTENSION 12
513 PULMONARY OEDEMA 12
514 RED BLOOD CELL COUNT DECREASED 12
515 RESPIRATORY FAILURE 12
516 SLEEP APNOEA SYNDROME 12
517 TOOTH INFECTION 12
518 ABNORMAL FAECES 11
519 BLOOD GLUCOSE ABNORMAL 11
520 BLOOD MAGNESIUM DECREASED 11
521 CORONARY ARTERIAL STENT INSERTION 11
522 EYE INJURY 11
523 FAECES SOFT 11
524 HAEMATEMESIS 11
525 HAEMOGLOBIN INCREASED 11
526 HEART RATE DECREASED 11
527 HYPOCHOLESTEROLAEMIA 11
528 HYPONATRAEMIA 11
529 HYPOXIA 11
530 INJECTION SITE RASH 11
531 MATERNAL EXPOSURE TIMING UNSPECIFIED 11
532 MYOCARDITIS 11
533 NEUROLEPTIC MALIGNANT SYNDROME 11
534 NEUTROPHIL COUNT DECREASED 11
535 PHOTOPHOBIA 11
536 PRODUCT PACKAGING ISSUE 11
537 SINUS CONGESTION 11
538 SNEEZING 11
539 ACNE 10
540 ANAL INCONTINENCE 10
541 ASCITES 10
542 BLOOD URINE PRESENT 10
543 CALCULUS URINARY 10
544 CARDIOVERSION 10
545 CHOLELITHIASIS 10
546 COELIAC DISEASE 10
547 COGNITIVE DISORDER 10
548 CONJUNCTIVITIS 10
549 DISEASE PROGRESSION 10
550 DISORIENTATION 10
551 DRUG DOSE OMISSION BY DEVICE 10
552 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10
553 DYSPNOEA EXERTIONAL 10
554 DYSURIA 10
555 EXTRA DOSE ADMINISTERED 10
556 FEELING COLD 10
557 FEMUR FRACTURE 10
558 GASTRIC ULCER HAEMORRHAGE 10
559 GASTROINTESTINAL PAIN 10
560 HYPERGLYCAEMIA 10
561 HYPERPHOSPHATAEMIA 10
562 INFUSION SITE PAIN 10
563 INTERVERTEBRAL DISC PROTRUSION 10
564 MICTURITION URGENCY 10
565 MIDDLE INSOMNIA 10
566 NOCTURIA 10
567 OSTEONECROSIS 10
568 PANCYTOPENIA 10
569 PLASMA CELL MYELOMA 10
570 PROSTATIC SPECIFIC ANTIGEN INCREASED 10
571 PROTEINURIA 10
572 PULMONARY MASS 10
573 RECALLED PRODUCT ADMINISTERED 10
574 RESTLESS LEGS SYNDROME 10
575 RIB FRACTURE 10
576 SEROTONIN SYNDROME 10
577 SKIN DISORDER 10
578 SPINAL FUSION SURGERY 10
579 SPINAL OPERATION 10
580 THROMBOCYTOPENIA 10
581 TUBULOINTERSTITIAL NEPHRITIS 10
582 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9
583 ATELECTASIS 9
584 BLOOD CHOLESTEROL ABNORMAL 9
585 BLOOD PRESSURE FLUCTUATION 9
586 BLOOD UREA INCREASED 9
587 BODY TEMPERATURE INCREASED 9
588 BREAST CANCER STAGE II 9
589 CARDIAC ABLATION 9
590 CHOLECYSTECTOMY 9
591 CLOSTRIDIUM DIFFICILE INFECTION 9
592 COLON CANCER 9
593 COVID-19 PNEUMONIA 9
594 CYTOKINE RELEASE SYNDROME 9
595 DERMATITIS 9
596 DERMATITIS ATOPIC 9
597 DEVICE LEAKAGE 9
598 DEVICE RELATED INFECTION 9
599 DRUG EFFECT LESS THAN EXPECTED 9
600 DYSKINESIA 9
601 DYSLIPIDAEMIA 9
602 ECONOMIC PROBLEM 9
603 ELECTROCARDIOGRAM ABNORMAL 9
604 ERECTILE DYSFUNCTION 9
605 FEELING JITTERY 9
606 GALLBLADDER DISORDER 9
607 GASTROENTERITIS VIRAL 9
608 HAEMOPTYSIS 9
609 HYDRONEPHROSIS 9
610 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 9
611 INCORRECT DOSE ADMINISTERED BY DEVICE 9
612 IRON DEFICIENCY ANAEMIA 9
613 LYMPHADENOPATHY 9
614 MITRAL VALVE INCOMPETENCE 9
615 MULTIPLE SCLEROSIS RELAPSE 9
616 NIGHTMARE 9
617 PANCREATITIS NECROTISING 9
618 PARKINSON^S DISEASE 9
619 PAROSMIA 9
620 PLEURITIC PAIN 9
621 POST PROCEDURAL COMPLICATION 9
622 PRODUCT DISTRIBUTION ISSUE 9
623 PRURITUS GENERALISED 9
624 RASH MACULAR 9
625 RESPIRATORY TRACT INFECTION 9
626 ROTATOR CUFF SYNDROME 9
627 SWOLLEN TONGUE 9
628 THROAT TIGHTNESS 9
629 THYROID DISORDER 9
630 ANGER 8
631 ANGINA UNSTABLE 8
632 APHASIA 8
633 ARTERIAL OCCLUSIVE DISEASE 8
634 ATRIAL FLUTTER 8
635 BLADDER CANCER 8
636 BLOOD BILIRUBIN INCREASED 8
637 BLOOD CALCIUM INCREASED 8
638 CARDIAC FAILURE CHRONIC 8
639 CARDIO-RESPIRATORY ARREST 8
640 CARDIOMEGALY 8
641 CEREBRAL HAEMORRHAGE 8
642 CHOKING SENSATION 8
643 CHOLECYSTITIS 8
644 FLANK PAIN 8
645 HISTOPLASMOSIS 8
646 HYPERSOMNIA 8
647 HYPOCHLORAEMIA 8
648 INCONTINENCE 8
649 INJECTION SITE URTICARIA 8
650 INTERNAL HAEMORRHAGE 8
651 JOINT DESTRUCTION 8
652 LEUKOCYTOSIS 8
653 LEUKOPENIA 8
654 MALIGNANT MELANOMA 8
655 MENTAL STATUS CHANGES 8
656 MOOD ALTERED 8
657 MUSCULOSKELETAL DISORDER 8
658 OROPHARYNGEAL DISCOMFORT 8
659 PARAESTHESIA ORAL 8
660 POLYARTHRITIS 8
661 POLYP 8
662 PRODUCT PREPARATION ERROR 8
663 PRODUCT TEMPERATURE EXCURSION ISSUE 8
664 RASH PAPULAR 8
665 RESPIRATORY SYMPTOM 8
666 SKIN CANCER 8
667 SPEECH DISORDER 8
668 SPINAL PAIN 8
669 STAPHYLOCOCCAL INFECTION 8
670 TRANSAMINASES INCREASED 8
671 TRICUSPID VALVE INCOMPETENCE 8
672 UPPER LIMB FRACTURE 8
673 URINARY INCONTINENCE 8
674 ALTERED STATE OF CONSCIOUSNESS 7
675 AORTIC STENOSIS 7
676 APPETITE DISORDER 7
677 ARTHROPOD BITE 7
678 BACTERAEMIA 7
679 BASAL CELL CARCINOMA 7
680 BLOOD IRON DECREASED 7
681 BLOOD SODIUM DECREASED 7
682 BLOOD THYROID STIMULATING HORMONE INCREASED 7
683 BONE LOSS 7
684 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 7
685 CATHETERISATION CARDIAC 7
686 CONGENITAL HIATUS HERNIA 7
687 CORONAVIRUS INFECTION 7
688 DECREASED ACTIVITY 7
689 DEVICE DELIVERY SYSTEM ISSUE 7
690 DEVICE USE ERROR 7
691 DIPLOPIA 7
692 FRACTURE 7
693 HAEMORRHOIDS 7
694 HEAD INJURY 7
695 HEPATITIS 7
696 HEPATOMEGALY 7
697 HYPERTHYROIDISM 7
698 ILEUS 7
699 INFUSION SITE SWELLING 7
700 INJECTION SITE DISCOLOURATION 7
701 INJECTION SITE DISCOMFORT 7
702 INTENTIONAL OVERDOSE 7
703 LACTIC ACIDOSIS 7
704 LOW DENSITY LIPOPROTEIN DECREASED 7
705 MALIGNANT MELANOMA STAGE 0 7
706 MULTIPLE-DRUG RESISTANCE 7
707 MUSCULOSKELETAL CHEST PAIN 7
708 NEEDLE ISSUE 7
709 ORAL CANDIDIASIS 7
710 PANNICULITIS 7
711 PERIPHERAL COLDNESS 7
712 PHARYNGEAL OEDEMA 7
713 PRODUCT CONTAMINATION 7
714 PRODUCT LABEL CONFUSION 7
715 PRODUCT PACKAGING QUANTITY ISSUE 7
716 RENAL PAIN 7
717 SKIN FISSURES 7
718 SKIN HAEMORRHAGE 7
719 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7
720 SPLENOMEGALY 7
721 SUICIDAL IDEATION 7
722 TENDON RUPTURE 7
723 TOOTHACHE 7
724 UPPER-AIRWAY COUGH SYNDROME 7
725 URINE ALBUMIN/CREATININE RATIO DECREASED 7
726 VENTRICULAR EXTRASYSTOLES 7
727 VITAMIN D DECREASED 7
728 ACCIDENT 6
729 ANALGESIC THERAPY 6
730 ANOSMIA 6
731 ANTACID THERAPY 6
732 ANTICOAGULANT THERAPY 6
733 ARTERIOSCLEROSIS 6
734 BLADDER DISORDER 6
735 BLOOD TESTOSTERONE DECREASED 6
736 BONE DEMINERALISATION 6
737 BREAST PAIN 6
738 BREATH SOUNDS ABNORMAL 6
739 CARTILAGE INJURY 6
740 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6
741 COLD SWEAT 6
742 CONGENITAL ANOMALY 6
743 CORONARY ARTERY STENOSIS 6
744 CYST 6
745 DEPRESSED LEVEL OF CONSCIOUSNESS 6
746 DEVICE OCCLUSION 6
747 DIABETES MELLITUS INADEQUATE CONTROL 6
748 DRUG THERAPY 6
749 EATING DISORDER 6
750 ENCEPHALOPATHY 6
751 EXTRASYSTOLES 6
752 EYE HAEMORRHAGE 6
753 FOETAL DEATH 6
754 FOOT OPERATION 6
755 FOREIGN BODY IN RESPIRATORY TRACT 6
756 GENERAL SYMPTOM 6
757 GINGIVAL BLEEDING 6
758 HIP FRACTURE 6
759 HYDROURETER 6
760 IMPAIRED WORK ABILITY 6
761 INITIAL INSOMNIA 6
762 INJECTION SITE INDURATION 6
763 INJECTION SITE WARMTH 6
764 KIDNEY INFECTION 6
765 LARGE INTESTINE POLYP 6
766 MALNUTRITION 6
767 MULTIPLE SCLEROSIS 6
768 MUSCLE STRAIN 6
769 MYOSITIS 6
770 NODULE 6
771 NON-CARDIAC CHEST PAIN 6
772 NORMAL NEWBORN 6
773 ORAL DISCOMFORT 6
774 ORAL PAIN 6
775 ORTHOSTATIC HYPOTENSION 6
776 OSTEONECROSIS OF JAW 6
777 PANIC ATTACK 6
778 PARANASAL SINUS HYPERSECRETION 6
779 PELVIC PAIN 6
780 PHARYNGEAL SWELLING 6
781 PHARYNGITIS STREPTOCOCCAL 6
782 PNEUMONIA BACTERIAL 6
783 POLYDIPSIA 6
784 PRE-EXISTING CONDITION IMPROVED 6
785 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6
786 PRODUCT COMMUNICATION ISSUE 6
787 PRODUCT SOLUBILITY ABNORMAL 6
788 PYELONEPHRITIS 6
789 RENAL CANCER 6
790 SHOULDER OPERATION 6
791 SLEEP DISORDER THERAPY 6
792 SPINAL STENOSIS 6
793 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 6
794 SUSPECTED PRODUCT CONTAMINATION 6
795 TENDON DISORDER 6
796 THERAPEUTIC RESPONSE SHORTENED 6
797 THROAT CANCER 6
798 UNRESPONSIVE TO STIMULI 6
799 URINE OUTPUT DECREASED 6
800 ABNORMAL BEHAVIOUR 5
801 ABNORMAL DREAMS 5
802 ADVERSE REACTION 5
803 AGGRESSION 5
804 ANKLE FRACTURE 5
805 BLOOD PRESSURE SYSTOLIC INCREASED 5
806 BREAST TENDERNESS 5
807 CARDIAC PACEMAKER INSERTION 5
808 CARPAL TUNNEL SYNDROME 5
809 COLONOSCOPY 5
810 COMA 5
811 CONCOMITANT DISEASE AGGRAVATED 5
812 DEAFNESS 5
813 DEMENTIA 5
814 DENTAL CARIES 5
815 DIVERTICULUM INTESTINAL 5
816 DRUG WITHDRAWAL SYNDROME 5
817 DRY THROAT 5
818 EAR DISCOMFORT 5
819 EJECTION FRACTION DECREASED 5
820 EOSINOPHIL COUNT INCREASED 5
821 ESSENTIAL HYPERTENSION 5
822 EXPOSURE VIA SKIN CONTACT 5
823 EYE INFECTION 5
824 EYE OPERATION 5
825 EYELID RASH 5
826 FEAR 5
827 FOOD POISONING 5
828 FOURNIER^S GANGRENE 5
829 FULL BLOOD COUNT DECREASED 5
830 GASTRIC CANCER 5
831 GASTRIC HAEMORRHAGE 5
832 GASTROENTERITIS 5
833 GRANULOMA 5
834 HAEMATOMA 5
835 HAIR DISORDER 5
836 HEAD DISCOMFORT 5
837 HIP SURGERY 5
838 HOSPICE CARE 5
839 HYPERCALCAEMIA 5
840 HYPERVOLAEMIA 5
841 HYPOKINESIA 5
842 IMMUNE-MEDIATED MYOCARDITIS 5
843 IMPAIRED QUALITY OF LIFE 5
844 INFUSION SITE ERYTHEMA 5
845 KNEE OPERATION 5
846 LIVER FUNCTION TEST ABNORMAL 5
847 METASTASES TO BONE 5
848 MOOD SWINGS 5
849 NEPHROPATHY 5
850 NERVE COMPRESSION 5
851 OESOPHAGEAL DISORDER 5
852 PANCREATITIS RELAPSING 5
853 PELVIC FRACTURE 5
854 PETECHIAE 5
855 PHYSICAL DECONDITIONING 5
856 PORTAL HYPERTENSION 5
857 PROCEDURAL PAIN 5
858 PRODUCT SUPPLY ISSUE 5
859 PROSTATIC OPERATION 5
860 PSYCHOTIC DISORDER 5
861 PULMONARY HYPERTENSION 5
862 PULMONARY TOXICITY 5
863 PUSTULAR PSORIASIS 5
864 RASH VESICULAR 5
865 RENAL CYST 5
866 RENAL FUNCTION TEST ABNORMAL 5
867 RESPIRATORY ARREST 5
868 RESTLESSNESS 5
869 SCRATCH 5
870 SENSITIVE SKIN 5
871 SENSORY DISTURBANCE 5
872 SKIN LACERATION 5
873 SKIN LESION 5
874 SKIN ULCER 5
875 SMALL INTESTINAL OBSTRUCTION 5
876 SPINAL FRACTURE 5
877 SUBDURAL HAEMATOMA 5
878 TENDON PAIN 5
879 TENDONITIS 5
880 THERAPY PARTIAL RESPONDER 5
881 TOOTH DISORDER 5
882 TOOTH LOSS 5
883 TOXICITY TO VARIOUS AGENTS 5
884 UPPER GASTROINTESTINAL HAEMORRHAGE 5
885 VENTRICULAR TACHYCARDIA 5
886 VITAMIN D DEFICIENCY 5
887 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5
888 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5
889 ACUTE RESPIRATORY DISTRESS SYNDROME 4
890 AGITATION 4
891 ANAPHYLACTIC SHOCK 4
892 ANGIOEDEMA 4
893 AORTIC ANEURYSM 4
894 APHONIA 4
895 ARTERIOSCLEROSIS CORONARY ARTERY 4
896 ATAXIA 4
897 ATRIAL SEPTAL DEFECT 4
898 BEDRIDDEN 4
899 BLOOD CHLORIDE DECREASED 4
900 BLOOD CREATINE INCREASED 4
901 BLOOD PRESSURE SYSTOLIC DECREASED 4
902 BLOOD TRIGLYCERIDES DECREASED 4
903 BONE DENSITY ABNORMAL 4
904 BRAIN INJURY 4
905 BRAIN NATRIURETIC PEPTIDE INCREASED 4
906 BRONCHITIS VIRAL 4
907 CHANGE OF BOWEL HABIT 4
908 CHOLECYSTITIS ACUTE 4
909 CUSHINGOID 4
910 CYTOMEGALOVIRUS INFECTION 4
911 DERMATITIS ALLERGIC 4
912 DERMATITIS CONTACT 4
913 DEVICE BREAKAGE 4
914 DEVICE PHYSICAL PROPERTY ISSUE 4
915 DIALYSIS 4
916 DISTRIBUTIVE SHOCK 4
917 DRUG ERUPTION 4
918 DUODENAL ULCER 4
919 DYSARTHRIA 4
920 DYSMENORRHOEA 4
921 ELECTROLYTE IMBALANCE 4
922 EMOTIONAL DISORDER 4
923 EMPHYSEMA 4
924 EXERCISE TOLERANCE DECREASED 4
925 EYE DISCHARGE 4
926 FACE INJURY 4
927 FRUSTRATION TOLERANCE DECREASED 4
928 GALLBLADDER OPERATION 4
929 GASTRIC DISORDER 4
930 GASTRITIS 4
931 GASTROINTESTINAL HYPOMOTILITY 4
932 GASTROINTESTINAL POLYP HAEMORRHAGE 4
933 GINGIVAL SWELLING 4
934 HAEMATOCRIT DECREASED 4
935 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4
936 HAEMORRHAGE URINARY TRACT 4
937 HAEMORRHOIDAL HAEMORRHAGE 4
938 HAIR COLOUR CHANGES 4
939 HEART RATE ABNORMAL 4
940 HEPATIC FIBROSIS 4
941 HEREDITARY ANGIOEDEMA 4
942 HYPERPHAGIA 4
943 HYPERURICAEMIA 4
944 HYPOCALCAEMIA 4
945 IMMUNE THROMBOCYTOPENIA 4
946 IMMUNE-MEDIATED HEPATIC DISORDER 4
947 IMMUNE-MEDIATED MYOSITIS 4
948 INABILITY TO AFFORD MEDICATION 4
949 INCORRECT PRODUCT ADMINISTRATION DURATION 4
950 INCORRECT PRODUCT STORAGE 4
951 INCREASED TENDENCY TO BRUISE 4
952 INFUSION SITE PRURITUS 4
953 INJECTION SITE IRRITATION 4
954 INTERVERTEBRAL DISC DEGENERATION 4
955 IRITIS 4
956 JAUNDICE 4
957 JOINT NOISE 4
958 LIGAMENT SPRAIN 4
959 LIQUID PRODUCT PHYSICAL ISSUE 4
960 LOW DENSITY LIPOPROTEIN ABNORMAL 4
961 LUNG NEOPLASM MALIGNANT 4
962 LUNG OPACITY 4
963 LYMPHOMA 4
964 MALABSORPTION 4
965 MELAENA 4
966 MENISCUS INJURY 4
967 METASTASES TO LIVER 4
968 MOUTH ULCERATION 4
969 MUSCLE ATROPHY 4
970 MUSCLE DISORDER 4
971 MUSCLE SPASTICITY 4
972 MYOCARDIAL ISCHAEMIA 4
973 NEOPLASM PROGRESSION 4
974 NEOPLASM SKIN 4
975 NON-SMALL CELL LUNG CANCER 4
976 ODYNOPHAGIA 4
977 OSTEOMYELITIS 4
978 PAIN OF SKIN 4
979 PAINFUL RESPIRATION 4
980 PANCREATIC CARCINOMA 4
981 PARALYSIS 4
982 PEPTOSTREPTOCOCCUS INFECTION 4
983 PERIORBITAL PAIN 4
984 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4
985 PERIPHERAL VASCULAR DISORDER 4
986 PHARYNGITIS 4
987 PIGMENTATION DISORDER 4
988 PNEUMOTHORAX 4
989 POLYMENORRHOEA 4
990 POST PROCEDURAL INFECTION 4
991 PREMATURE DELIVERY 4
992 PRODUCT CONTAMINATION PHYSICAL 4
993 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4
994 PRODUCT PHYSICAL CONSISTENCY ISSUE 4
995 PRODUCT PRESCRIBING ISSUE 4
996 PROTEIN URINE PRESENT 4
997 PULMONARY ALVEOLAR HAEMORRHAGE 4
998 PULMONARY THROMBOSIS 4
999 RADIUS FRACTURE 4